Drug Discovery Services

10th April to 12th April 2017
Domainex will be exhibiting at the BNA2017 Festival of Neuroscience and invites you to come and find out more about our services and our prestigious Discovery STAR award.
11th June to 14th June 2017
Domainex will attend the 1st Anglo-Nordic Medicinal Chemistry Symposium, showcasing the very best research in medicinal chemistry and related technologies.
6th June to 9th June 2017
Domainex will be presenting at the Novalix Biophysics Conference in Drug Discovery 2017 and showcasing FragmentBuilder on our exhibition stand.
8th May to 10th May 2017
Dr Tom Mander will be presenting at BioTrinity 2017 and looks forward to discussing how Domainex can support your drug discovery programme.
6th March to 7th March 2017
Advances in Drug Discovery is a multi-track event in medicinal chemistry, focusing on epigenetics, antibodies, academic and stem cell drug discovery.
2nd March 2017
Launch of the MRC Confidence in Concept scheme, which awards universities grants to help fast track promising research ideas towards clinical testing.
20th March to 22nd March 2017
Find out how Domainex can support your drug discovery programme at BIO-Europe Spring – the partnering conference for biotech, pharma and finance.
5th March to 7th March 2017
Fragments 2017 meeting will focus on Fragment-based drug discovery where Domainex will be showcasing FragmentBuilder.
23rd April to 27th April 2017
Domainex will be showcasing FragmentBuilder and presenting a case study on the lysine methyltransferase, G9a, as part of the Fragment-based drug discovery track.
Domainex has purchased a Monolith NT. Automated instrument, using MicroScale Thermophoresis (MST) technology for high-throughput fragment-based drug discovery.